It seems, as with Ern, that producing context and proof of "conversations"
is not within your scope of curiosity let alone due diligence.
Questioning ambiguity is NOT accusing someone of lying.
Whatever motivated Anavex to submit the MAA it will not be the
false hope of encouragement by the EMA, if their decision is unfavorable.
Most are willing to accept the process as a valid procedure toward approval.
Some will consider an outcome anything other than ideal as somehow corrupt.
Some will hold Anavex blameless for any fractured timelines or Market reaction.
Some ultimately will treat Blarcamesine as a novel approach which may lead
to further scientific investigation of CNS diseases in general.
Of ALL those scenarios I know which is most likely.
I will invest/trade in AVXL based upon those realities not the hopes and promises
of a specific echo chamber.
It is a shame that balanced consideration of information seems lost on
an intolerant group unwilling to enjoin civil discourse of as yet uncertain events.
For those who insist on that certainty, buy a backup Magic Eightball.
The decision of the EMA is coming of that I am certain. One of the
fringe opinions of its content will hope to be correct while denigrating
both the informed middle and the mirror image of themselves for sport.
In the meantime it seems prudent to await a MARKET reaction to REAL NEWS.
The falling knife that is AVXL may be close to hitting the floor,
but we have been here before. Some have the scars to prove it.
Market Data 
Markets 
AI
